Sato, Akira
Morishima, Toshitaka
Takeuchi, Masato
Nakata, Kayo
Kawakami, Koji
Miyashiro, Isao
Funding for this research was provided by:
Grant-in-Aid for Early-Career Scientists from the Japan Society for the Promotion of Science (JP20K18869)
Taiju Life Social Welfare Foundation
Ministry of Health, Labour and Welfare of Japan (H30-Gantaisaku-Ippan-009)
Article History
Received: 30 August 2022
Accepted: 2 March 2023
First Online: 15 March 2023
Competing interests
: K. Kawakami has received research funds from Eisai Co., Ltd.; Kyowa Kirin Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Pfizer Inc.; Stella Pharma Corporation; CMIC Co., Ltd.; Suntory Beverage & Food Ltd.; Mitsubishi Corporation, and Real World Data Co., Ltd.; consulting fees from LEBER Inc.; JMDC Inc.; Shin Nippon Biomedical Laboratories Ltd.; Kaken Pharmaceutical Co., Ltd.; and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems, Inc.; honoraria from Mitsubishi Chemical Holdings Corporation, Mitsubishi Corporation, Pharma Business Academy, and Toppan Inc.; and holds stock in Real World Data Co., Ltd. The sponsors had no control over the interpretation, writing, or publication of this work. No potential conflicts of interest were disclosed by the other authors.